These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8290256)
1. Growth suppression of normal mammary epithelial cells by wild-type p53. Merlo GR; Venesio T; Taverna D; Marte BM; Callahan R; Hynes NE Oncogene; 1994 Feb; 9(2):443-53. PubMed ID: 8290256 [TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785 [TBL] [Abstract][Full Text] [Related]
3. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Gollahon LS; Shay JW Oncogene; 1996 Feb; 12(4):715-25. PubMed ID: 8632893 [TBL] [Abstract][Full Text] [Related]
4. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748 [TBL] [Abstract][Full Text] [Related]
5. Growth suppression of normal mammary epithelial cells by wild-type p53. Merlo GR; Venesio T; Taverna D; Callahan R; Hynes NE Ann N Y Acad Sci; 1993 Nov; 698():108-13. PubMed ID: 8279747 [TBL] [Abstract][Full Text] [Related]
6. Regulation of gene expression in mammary epithelial cells by cellular confluence and sequence-specific DNA binding factors. Altiok S; Groner B Biochem Soc Symp; 1998; 63():115-31. PubMed ID: 9513716 [TBL] [Abstract][Full Text] [Related]
7. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors. Merlo GR; Graus-Porta D; Cella N; Marte BM; Taverna D; Hynes NE Eur J Cell Biol; 1996 Jun; 70(2):97-105. PubMed ID: 8793381 [TBL] [Abstract][Full Text] [Related]
8. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells. Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706 [TBL] [Abstract][Full Text] [Related]
9. p53 mutations in spontaneously immortalized 3T12 but not 3T3 mouse embryo cells. Rittling SR; Denhardt DT Oncogene; 1992 May; 7(5):935-42. PubMed ID: 1349164 [TBL] [Abstract][Full Text] [Related]
10. Evidence for the transforming activity of a truncated Int6 gene, in vitro. Rasmussen SB; Kordon E; Callahan R; Smith GH Oncogene; 2001 Aug; 20(38):5291-301. PubMed ID: 11536042 [TBL] [Abstract][Full Text] [Related]
11. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons. Balcer-Kubiczek EK; Yin J; Lin K; Harrison GH; Abraham JM; Meltzer SJ Radiat Res; 1995 Jun; 142(3):256-62. PubMed ID: 7761574 [TBL] [Abstract][Full Text] [Related]
12. The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. Venesio T; Taverna D; Hynes NE; Deed R; MacAllan D; Ciardiello F; Valverius EM; Salomon DS; Callahan R; Merlo G Cell Growth Differ; 1992 Jan; 3(1):63-71. PubMed ID: 1376141 [TBL] [Abstract][Full Text] [Related]
13. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Ozbun MA; Jerry DJ; Kittrell FS; Medina D; Butel JS Cancer Res; 1993 Apr; 53(7):1646-52. PubMed ID: 8453637 [TBL] [Abstract][Full Text] [Related]
14. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation. Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910 [TBL] [Abstract][Full Text] [Related]
15. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]. Wang H; Lai B; Li J Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947 [TBL] [Abstract][Full Text] [Related]
16. p53 mutations in mouse mammary epithelial cells: instability in culture and discordant selection of mutations in vitro versus in vivo. Ozbun MA; Medina D; Butel JS Cell Growth Differ; 1993 Oct; 4(10):811-9. PubMed ID: 8274450 [TBL] [Abstract][Full Text] [Related]
17. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504 [TBL] [Abstract][Full Text] [Related]
18. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor. Happ B; Hynes NE; Groner B Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907 [TBL] [Abstract][Full Text] [Related]
19. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cao Y; Gao Q; Wazer DE; Band V Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971 [TBL] [Abstract][Full Text] [Related]
20. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]